You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
長春高新(000661.SZ):子公司流感病毒裂解疫苗臨牀試驗申請獲得批准
格隆匯 06-19 19:21

格隆匯6月19日丨長春高新(000661.SZ)公佈,子公司長春百克生物科技股份公司(簡稱“百克生物”)收到國家藥品監督管理局核准簽發的《藥物臨牀試驗批准通知書》,百克生物流感病毒裂解疫苗(BK-01佐劑)臨牀試驗申請獲得批准。本次百克生物獲批臨牀的流感病毒裂解疫苗(BK-01佐劑)接種對象為60歲及以上人羣,接種後可刺激機體產生更強的免疫應答,用於預防流感病毒引發的流行性感冒。該疫苗採用流感病毒裂解疫苗工藝技術路線,配伍以百克生物自主研發的佐劑,保證疫苗安全性的同時提高了疫苗的免疫原性,與傳統裂解流感疫苗相比,可激發機體產生更高水平的保護性抗體。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account